Medical and Pharmaceutical Acurx Pharma shares rise by 29% on new trial for breakthrough antibiotic ‘ibezapolstat’ Investors are optimistic about the therapeutic's potential as a superior alternative for CDI treatment Rowan DunneMarch 11, 2026
AI and Autonomy Light AI develops smartphone tech for diagnosing severe throat infection The Vancouver-based medical equipment company completed its IPO earlier this month Rowan DunneJanuary 29, 2025
AI and Autonomy Researchers create antibiotic designing AI model for dangerous bacteria The Canadian Institutes of Health Research contributed funding for the initiative Rowan DunneMarch 22, 2024